Fig. 1From: Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibitionCNS response following radiotherapy and immunotherapy. a CNS lesions following gamma knife surgery (GKS), prior to whole brain radiation therapy (WBRT) and Talimogene laherparepvec (T-Vec). b Three months post WBRT and initiation of T-Vec (c) Six months following T-VecBack to article page